BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 2.85 | 4.82 | 9.83 | 6.13 | 8.18 |
What is the latest Profit After Tax (PAT) Margin ratio of BAFNA PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 2.85 |
| Mar2024 | 4.82 |
| Mar2023 | 9.83 |
| Mar2022 | 6.13 |
| Mar2021 | 8.18 |
How is Profit After Tax (PAT) Margin of BAFNA PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 2.85 | -40.87 | |
| Mar2024 | 4.82 | -50.97 | |
| Mar2023 | 9.83 | 60.36 | |
| Mar2022 | 6.13 | -25.06 | |
| Mar2021 | 8.18 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹263.1 Cr | -12% | -25.8% | 45.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -12% |
-25.8% |
45.9% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses